Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey D Varner

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Arxiv|April 10, 2026
ParetoEnsembles.jl: A Julia Package for Multiobjective Parameter Estimation Using Pareto Optimal Ensemble TechniquesJeffrey D Varner
Arxiv|March 30, 2026
BSTModelKit.jl: A Julia Package for Constructing, Solving, and Analyzing Biochemical Systems Theory ModelsSandra Vadhin, Jeffrey D Varner
Plos Computational Biology|July 31, 2007
Computationally derived points of fragility of a human cascade are consistent with current therapeutic strategiesDeyan Luan, Michael Zai, Jeffrey D Varner
Biotechnology and Bioengineering|August 3, 2011
A review of the mammalian unfolded protein responseAnirikh Chakrabarti, Aaron W Chen, Jeffrey D Varner
Biotechnology Journal|July 29, 2010
Ensembles of signal transduction models using Pareto Optimal Ensemble Techniques (POETs)Sang Ok Song, Anirikh Chakrabarti, Jeffrey D Varner
Theoretical Biology & Medical Modelling|February 16, 2019
Analysis of the role of thrombomodulin in all-trans retinoic acid treatment of coagulation disorders in cancer patientsHamed Ghaffari, Jeffrey D Varner, Linda R Petzold
Current Opinion in Biotechnology|August 30, 2008
Engineering the spatial organization of metabolic enzymes: mimicking nature's synergyRobert J Conrado, Jeffrey D Varner, Matthew P DeLisa
ACS Synthetic Biology|June 6, 2015
Generating Effective Models and Parameters for RNA Genetic CircuitsChelsea Y Hu, Jeffrey D Varner, Julius B Lucks
Plos Computational Biology|November 22, 2011
Computational modeling and analysis of insulin induced eukaryotic translation initiationJoshua Lequieu, Anirikh Chakrabarti, Satyaprakash Nayak, et al.
Plos One|April 24, 2008
A test of highly optimized tolerance reveals fragile cell-cycle mechanisms are molecular targets in clinical cancer trialsSatyaprakash Nayak, Saniya Salim, Deyan Luan, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Arxiv|April 10, 2026
ParetoEnsembles.jl: A Julia Package for Multiobjective Parameter Estimation Using Pareto Optimal Ensemble TechniquesJeffrey D Varner
Arxiv|March 30, 2026
BSTModelKit.jl: A Julia Package for Constructing, Solving, and Analyzing Biochemical Systems Theory ModelsSandra Vadhin, Jeffrey D Varner
Plos Computational Biology|July 31, 2007
Computationally derived points of fragility of a human cascade are consistent with current therapeutic strategiesDeyan Luan, Michael Zai, Jeffrey D Varner
Biotechnology and Bioengineering|August 3, 2011
A review of the mammalian unfolded protein responseAnirikh Chakrabarti, Aaron W Chen, Jeffrey D Varner
Biotechnology Journal|July 29, 2010
Ensembles of signal transduction models using Pareto Optimal Ensemble Techniques (POETs)Sang Ok Song, Anirikh Chakrabarti, Jeffrey D Varner
Theoretical Biology & Medical Modelling|February 16, 2019
Analysis of the role of thrombomodulin in all-trans retinoic acid treatment of coagulation disorders in cancer patientsHamed Ghaffari, Jeffrey D Varner, Linda R Petzold
Current Opinion in Biotechnology|August 30, 2008
Engineering the spatial organization of metabolic enzymes: mimicking nature's synergyRobert J Conrado, Jeffrey D Varner, Matthew P DeLisa
ACS Synthetic Biology|June 6, 2015
Generating Effective Models and Parameters for RNA Genetic CircuitsChelsea Y Hu, Jeffrey D Varner, Julius B Lucks
Plos Computational Biology|November 22, 2011
Computational modeling and analysis of insulin induced eukaryotic translation initiationJoshua Lequieu, Anirikh Chakrabarti, Satyaprakash Nayak, et al.
Plos One|April 24, 2008
A test of highly optimized tolerance reveals fragile cell-cycle mechanisms are molecular targets in clinical cancer trialsSatyaprakash Nayak, Saniya Salim, Deyan Luan, et al.
Pageof 5